Our unparalleled insight into renal disease and patient care makes Frenova the trusted patient-centric authority for protocol design consultation in clinical trials involving kidney patients anywhere in the world. Our protocol design support translates to eased study execution for investigative sites, boosts operational efficiency, improves patient adherence and helps you avoid costly, time-consuming protocol revisions.
Partner With a Global Organization That Understands Renal Patient Care
Obtain guidance for the development of protocols that dovetail with standard of care while mitigating cost and risk. Simplified yet robust protocol design is especially important for successful study execution in renal research.
Take the Guesswork Out of Research Site Selection and Clinical Trial Feasibility
Frenova operates at the intersection of research and care, allowing us to provide effective, real-world-tested and reliable recommendations for global site selection and study execution for CKD and ESRD patients.
Focus on the Most Efficient Path to Approval
Get help determining how a product candidate will be used in the real world so you can choose the most efficient route to approval. From clinical trial feasibility and location selection to clinical research patient recruitment, Frenova evaluates strategies and assesses factors that could impact your research. Rely on our F1RST Up® Site Network to accelerate site startup.
Utilize the World’s Largest Renal Treatment Database
Gain exclusive access to FMC patient dialysis treatment data. Comprising data collected for 25 years, the database opens the door to historical data on 400,000 patients (U.S.: more than 200,000; ROW: 200,000) with chronic kidney disease (CKD) and close to a million with end stage renal disease (ESRD). We also have current data on around a hundred thousand active CKD patients and nearly 400,000 (U.S.: 300,000; ROW: 100,000) active ESRD patients.